Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994

J Am Acad Dermatol. 1998 Jul;39(1):43-7. doi: 10.1016/s0190-9622(98)70400-1.

Abstract

Background: Dermatologists have greater accuracy than nondermatologists for diagnosis of skin disease. However, it is not clear whether this affects medical outcome.

Objective: We tested the hypothesis that nondermatologists would be more likely than dermatologists to prescribe combination products for the treatment of common fungal skin infections.

Methods: We analyzed office-based physician visits for fungal skin infections recorded in the 1990-1994 National Ambulatory Medical Care Survey.

Results: There were 4.1 million visits for cutaneous fungal disease of which 82% were to nondermatologists. Nondermatologists were more likely to prescribe combination agents (34.1%) than dermatologists (4.8%, p=0.001). If the percentage of combination agents used by nondermatologists was reduced to that of dermatologists, an estimated $24.9 million or $10.3 million would be saved if clotrimazole or ketoconazole, respectively, were the substituted drug for the combination agent clotrimazole/betamethasone dipropionate.

Conclusion: Nondermatologists are more likely to use a more expensive, less effective regimen than are dermatologists, suggesting that dermatologists are more cost-effective than nondermatologists in the treatment of common fungal skin disorders.

MeSH terms

  • Administration, Topical
  • Ambulatory Care
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / economics
  • Anti-Inflammatory Agents / therapeutic use*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / economics
  • Antifungal Agents / therapeutic use*
  • Betamethasone / administration & dosage
  • Betamethasone / analogs & derivatives
  • Betamethasone / economics
  • Betamethasone / therapeutic use
  • Clotrimazole / administration & dosage
  • Clotrimazole / economics
  • Clotrimazole / therapeutic use
  • Cost Savings
  • Cost-Benefit Analysis
  • Dermatology*
  • Dermatomycoses / drug therapy*
  • Drug Combinations
  • Drug Costs
  • Family Practice
  • Glucocorticoids
  • Humans
  • Ketoconazole / administration & dosage
  • Ketoconazole / economics
  • Ketoconazole / therapeutic use
  • Office Visits
  • Pediatrics
  • Practice Patterns, Physicians'*
  • Tinea / drug therapy
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antifungal Agents
  • Drug Combinations
  • Glucocorticoids
  • betamethasone-17,21-dipropionate
  • Betamethasone
  • Clotrimazole
  • Ketoconazole